Related Experiment Videos
Screening for congenital heart disease
1Department of Obstetrics and Gynecology, Columbia University Medical Center, PH-16, 622 West 168th Street, New York, NY 10032, USA. ls731@columbia.edu
Obstetrics and Gynecology Clinics of North America
|April 6, 2004
Summary
Routine prenatal screening for congenital heart disease (CHD) is recommended, as current methods detect only 15-30% of cases. Improving detection rates through enhanced screening protocols is crucial for better infant outcomes.
Area of Science:
- Medical screening
- Prenatal diagnostics
- Cardiology
Background:
- Congenital heart disease (CHD) is a significant concern in neonates.
- Current prenatal screening methods, like the four-chamber view, have limited sensitivity (40-50%).
- Most infants with CHD are born to low-risk mothers, highlighting the need for broader screening.
Purpose of the Study:
- To emphasize the suitability of CHD for screening.
- To advocate for routine prenatal screening for congenital heart disease.
- To highlight the benefits of early prenatal diagnosis of CHD.
Main Methods:
- Utilizing the four-chamber view as an initial screening tool.
- Employing multiple cardiac views to enhance detection rates.
- Reviewing the current limitations of prenatal ultrasonography in identifying CHD.
Main Results:
- The four-chamber view detects 40-50% of CHD cases.
- Multiple cardiac views increase prenatal detection to 60-80%.
- Current prenatal diagnosis identifies only 15-30% of infants with CHD.
Conclusions:
- Routine prenatal screening for CHD is warranted due to its high prevalence and the limitations of current detection methods.
- Early diagnosis of CHD allows for comprehensive management, including genetic counseling and specialized delivery planning.
- There is a critical need to improve prenatal detection rates for congenital heart disease.